phrykt

Balchem Corp (BCPC): who owns it and who trades it

As of Nov 16, 2026, BCPC insiders reported 4 open-market sales worth $2.2M and no purchases in the last 12 months, with 0% of the sale value made under pre-set 10b5-1 plans. The largest seller was David B Fischer (Director), with $1.2M. 7 of the 50 famous funds we follow held it at their last quarter end.

Latest filing Nov 16, 2026. From Form 4, 13F and Schedule 13D/G filings.

At a glance

Who is buying and selling Balchem

From the latest filings

Overall: about as much buying as selling. Insiders mostly sold. Famous investors and Congress mostly bought. Funds was close to even.

Mostly sellingEvenMostly buying

Each group counts equally in the meter, by the number of buyers and sellers, not dollars. Insider sales under pre-set 10b5-1 plans are left out of it. From SEC, House and Senate filings; not advice.

Who owns BCPC

413 funds and institutions reported BCPC shares worth $5B at the end of Q2 2026, about 91% of the company. The largest holder is BlackRock, Inc. with 15.5%.

Funds and institutions (13F) 91%Everyone else 9%

10 largest owners, by share of the company

BlackRock, Inc.15.5%
Vanguard Portfolio Management LLC6.9%
Vanguard Capital Management LLC4.5%
State Street Corp4.0%
Geode Capital Management, LLC3.5%
Conestoga Capital Advisors, LLC3.4%
Wasatch Advisors LP3.3%
Morgan Stanley2.6%
Geneva Capital Management LLC2.1%
First Trust Advisors LP1.9%

Top 20 owners

OwnerShares% of companyValueChange since Q1 2026
BlackRock, Inc.4.96M15.45%$839M+3%
Vanguard Portfolio Management LLC2.22M6.91%$375M+1%
Vanguard Capital Management LLC1.45M4.50%$244M+1%
State Street Corp1.28M3.99%$217M+3%
Geode Capital Management, LLC1.12M3.49%$190M+7%
Conestoga Capital Advisors, LLC1.09M3.39%$184M-13%
Wasatch Advisors LP1.05M3.27%$178M-26%
Morgan Stanley834,4452.60%$141M-3%
Geneva Capital Management LLC683,1022.13%$115M-19%
First Trust Advisors LP617,2331.92%$104M+36%
Dimensional Fund Advisors LP610,0471.90%$103M+2%
FMR LLC (Fidelity)560,2551.74%$94.7M-6%
Congress Asset Management Co502,5711.56%$84.9M+13%
Two Sigma Investments, LP502,0381.56%$84.8M+17%
Schroder Investment Management Group440,4181.37%$74.5M+22%
Nuveen, LLC414,3671.29%$70M+5%
Norges Bank411,8761.28%$69.6M–
Northern Trust Corp384,1721.20%$64.9M+3%
Charles Schwab Investment Management Inc374,6131.17%$63.3M+1%
Sixth Street Partners Management Company, L.P.374,6131.17%$63.3M–

From the SEC 13F data sets: every fund manager with over $100M must report its US stock holdings every 3 months, up to 45 days after the quarter ends. Owners are shown as they file, so one group (for example Vanguard) can appear under several names. Individuals, most insiders and smaller funds do not file 13F reports.

Insider trades

In the last 12 months, BCPC insiders reported $0 of open-market purchases and $2.2M of sales. 0% of the sale value was under a 10b5-1 plan, a schedule set up in advance.

Purchases, 12 months
$0
0 trades, 0 people
Sales, 12 months
$2.2M
4 trades, 2 people
Sales under a 10b5-1 plan
0%
Share of sale value
Latest trade
Dec 4, 2025
Filed Dec 5, 2025

Purchases and sales by month

$2.2M$2.2MDecFebAprJunAugOct
Purchases Sales Click a bar to show only that month below

Latest trades

DateInsiderRoleTypeSharesPriceValueFiling
Dec 4, 2025Gunsteren Job Leonard vanVice presidentSale4,235$153.07$648KForm 4
Dec 4, 2025Gunsteren Job Leonard vanVice presidentSale1,765$153.80$271KForm 4
Dec 3, 2025David B FischerDirectorSale2,000$154.15$308KForm 4
Dec 3, 2025David B FischerDirectorSale6,000$153.91$923KForm 4

Insiders by value traded

InsiderRoleBoughtSoldLast trade
David B FischerDirector–$1.2MDec 3, 2025
Gunsteren Job Leonard vanSVP and GM, Specialty Products–$920KDec 4, 2025
What this data shows, and what it doesn't
  • Shows: open-market purchases and sales by officers, directors and 10%+ owners, reported on Form 4 within two business days of the trade.
  • Leaves out: stock awards, option exercises, shares withheld for tax and gifts. These are not trades at a market price chosen by the insider.
  • "plan" marks a sale made under a Rule 10b5-1 plan, a schedule set up in advance.
  • Fund holders come from 13F reports, a snapshot at quarter end filed up to 45 days later.
  • Filings are self-reported and can be amended. Each trade links to its original filing. Methodology

BCPC short interest

Low short interest. 1.6% of BCPC shares are sold short: about 1 share in 63. Over the last 12 reports the number of shares short went up 35%.

As a rough guide, under 5% is low, 5–10% is moderate, 10–20% is high and over 20% is very high.

0%5%10%15%20%+

As of Oct 30, 2026, 503,644 BCPC shares were sold short, 1.6% of the shares outstanding, down 2.6% from the report before. At the average daily volume of 336,808 shares, buying them all back would take about 1.5 trading days (days to cover).

Shares short, % of all shares

1.58%May 15Oct 302.06%

Days to cover

1.5May 15Oct 303.8

Every report

Settlement dateShares short% of sharesChangeAvg daily volumeDays to cover
Oct 30, 2026503,6441.58%-3%336,8081.5
Oct 15, 2026517,0491.63%+5%263,9732.0
Sep 30, 2026493,0111.55%-20%236,9692.1
Sep 15, 2026620,0411.95%+12%187,7753.3
Aug 31, 2026554,8401.74%-8%159,2443.5
Aug 14, 2026605,0611.90%+10%177,8633.4
Jul 31, 2026552,3491.73%-9%198,6222.8
Jul 15, 2026604,5221.88%+17%239,0562.5
Jun 30, 2026516,9021.61%+23%330,7861.6
Jun 15, 2026419,4541.31%+1%220,0961.9
May 29, 2026415,6301.29%+11%159,2232.6
May 15, 2026374,1201.16%+9%175,5962.1

Short sellers borrow shares and sell them, hoping to buy them back for less. A high number means many such bets are open. It does not say where the price will go. Source: FINRA equity short interest, reported by brokers twice a month (positions on the 15th and the last business day) and published about 7 business days later. % of shares uses the share count on the company's latest SEC filing. What short interest means · Most shorted stocks

Members of Congress who traded BCPC

Since Nov 17, 2024, 2 members of Congress reported 2 purchases and 1 sale of BCPC. The latest was a purchase by Gilbert Ray Cisneros, Jr. on Sep 17, 2026, reported Oct 12, 2026.

Purchases 2Sales 1

Reported trades

Trade dateMemberTypeAmountOwnerReportedSource
Sep 17, 2026Gilbert Ray Cisneros, Jr. (D-CA)Purchase$1K–$15KSelfOct 12, 2026Report
Jul 10, 2026Gilbert Ray Cisneros, Jr. (D-CA)Purchase$1K–$15KSelfSep 4, 2026Report
Apr 9, 2025Josh Gottheimer (D-NJ)Partial sale$1K–$15KJointMay 14, 2025Report

Source: Periodic Transaction Reports filed with the Clerk of the House and the Secretary of the Senate under the STOCK Act. Members report each trade within 45 days, as a dollar range, not an exact amount. Trades by a spouse or dependent child are included and marked. Paper filings (scanned images) are not included, and Senate reports are shown for current senators only. Links to Senate reports open the Senate’s own site, which shows its terms first and can only be reached from the United States. How these reports work

Balchem company events

Balchem filed 8 reports on Form 8-K in the last 12 months, 1 of them about an important change (leadership). The latest was on Oct 23, 2026.

  1. Oct 23, 2026ResultsReleased financial results. Filing
  2. Jul 31, 2026ResultsReleased financial results. Filing
  3. Jul 27, 2026AgreementBalchem Corporation, a Maryland corporation, together with its foreign subsidiary Balchem B.V., and certain domestic subsidiaries acting as guarantors, entered into Amendment No. 1 to that certain Amended and Restated Credit Agreement, dated as of July 27, 2022 with JPMorgan Chase Bank, N.A. and… Filing
  4. Jun 22, 2026VoteReported shareholder vote results. Filing
  5. Apr 30, 2026ResultsReleased financial results. Filing
  6. Feb 20, 2026ResultsReleased financial results. Filing
  7. Feb 19, 2026LeadershipAs previously announced by Balchem Corporation on March 3, 2025, William A. Backus, Vice President and Chief Accounting Officer, is retiring from his position on March 31, 2026. Filing
  8. Dec 10, 2025AnnouncementShared information with investors. Filing

From 8-K reports, which a company must file within 4 business days of an important event. Where a report is about a change such as a new CEO, the sentence is the first one from the report itself, shortened. Each row links to the original filing. Company events this week

Balchem financials

Famous investors that hold BCPC

7 of the 50 well-known investors we track reported holding BCPC in their latest 13F filing. The largest position is Jeremy Grantham's, worth $36.1M.

Position size

All holders

FundQuarterSharesValueOf portfolioChange
Jeremy Grantham · GMOQ3 2026219,092$36.1M0.1%+1%
Jim Simons · Renaissance TechnologiesQ3 2026167,900$27.7M0.0%-13%
Ken Griffin · Citadel AdvisorsQ3 202676,974$12.7M0.0%+25%
Israel Englander · Millennium ManagementQ3 202674,547$12.3M0.0%-60%
Steve Cohen · Point72 Asset ManagementQ3 202672,774$12M0.0%+182%
Ray Dalio · Bridgewater AssociatesQ3 202614,571$2.4M0.0%+9%
Paul Tudor Jones · Tudor Investment CorpQ3 202613,058$2.2M0.0%New

From 13F reports: a snapshot at quarter end, filed up to 45 days later. Change compares with the quarter before.

Questions about Balchem Corp (BCPC) stock

Who owns the most BCPC stock?

The largest reported owner of Balchem Corp (BCPC) is BlackRock, Inc., with 15.5% of the company. In total, 413 funds and institutions reported holding BCPC at the end of Q2 2026, together about 91% of the shares. See the largest owners.

Are BCPC insiders buying or selling?

In the last 12 months, BCPC insiders reported no open-market purchases and 4 sales worth $2.2M. The latest trade was on Dec 4, 2025. See every trade.

What is the short interest in BCPC?

As of Oct 30, 2026, 503,644 BCPC shares were sold short, 1.6% of the shares outstanding, down 2.6% from the report before. At the average daily volume of 336,808 shares, buying them all back would take about 1.5 trading days (days to cover). See the history.

Have members of Congress traded BCPC?

Yes. 2 members of Congress reported 2 purchases and 1 sale of BCPC since Nov 17, 2024. The latest was reported on Oct 12, 2026. See the trades.

Which famous investors hold BCPC?

7 of the 50 well-known investors we track reported BCPC in their latest 13F filing, including Jeremy Grantham, Jim Simons, Ken Griffin. The largest position is worth $36.1M. See all holders.

Executive pay

Balchem's chief executive was paid a total of $7.9M for the year ended Dec 31, 2025, up 15% from $6.9M the year before. In the last 12 months, Balchem's executives and directors bought no stock on the open market and sold $2.2M.

Chief executive, total pay$7.9MYear ended Dec 31, 2025. Salary, bonus and the value of stock and option awards when granted.
Pay "actually paid"$4.9MThe same year, with stock awards valued at what they were worth as they vested or at year end.
Other top executives, average$2.4MThe other officers named in the proxy statement.

From the pay versus performance table in the company's annual proxy statement (DEF 14A), as the company reported it. If the chief executive changed during the year, the company reports each person separately and this shows one of them.

Source: SEC Form 4 (insiders, filed within 2 business days), 13F (funds, up to 45 days after quarter end) and Schedule 13D/13G filings. Only open-market purchases (code P) and sales (code S) are shown. Data only, not investment advice. How we collect it.